A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Inclusion Criteria: 1. Male or female, 18-45 years old, inclusive; 2. BMI: 20.0 to 30.0 kg/m2 , body weight: ≥50.0kg. 3. Ability and willingness to participate in the study, give written informed consent, and comply with the study requirements and all protocol procedures. Exclusion Criteria: 1. Presence of clinically significant conditions (including but not limited to respiratory system, cardiovascular system, gastrointestinal system, endocrine system, immune system, integumentary system, nervous system, ENT or other related diseases); 2. History of allergic diseases including asthma, urticaria or eczema, or history of sensitivity to GLP-1 products, digoxin, warfarin, rosuvastatin or metformin; 3. Known difficulty in swallowing tablets or history of gastrointestinal diseases affecting drug absorption; 4. History of receiving any procedures that might affect drug absorption, distribution, metabolism or excretion; 5. History of acute or chronic pancreatitis; 6. History of documented or suspected hypoglycemic episodes within 6 months prior to screening;